Researchers have identified many of the biomarkers for Alzheimer's disease that could potentially predict which patients will develop the disorder later in life.
Now, studying spinal fluid samples and health data from 201 research participants at the Charles F. and Joanne Knight Alzheimer's Disease Research Center, scientists at Washington University School of Medicine in St. Louis have shown the markers are accurate predictors of Alzheimer's years before symptoms develop.
Risk Factors for Alzheimers Disease
Cognitively normal adults exhibiting atrophy of their temporal lobe or damage to blood vessels in the brain are more likely to develop Alzheimer's disease.
Advertisement
The researchers evaluated markers such as the buildup of amyloid plaques in the brain, newly visible thanks to an imaging agent developed in the last decade; levels of various proteins in the cerebrospinal fluid, such as the amyloid fragments that are the principal ingredient of brain plaques; and the ratios of one protein to another in the cerebrospinal fluid, such as different forms of the brain cell structural protein tau.
The markers were studied in volunteers whose ages ranged from 45 to 88. On average, the data available on study participants spanned four years, with the longest recorded over 7.5 years.
The researchers found that all of the markers were equally good at identifying subjects who were likely to develop cognitive problems and at predicting how soon they would become noticeably impaired.
Next, the scientists paired the biomarkers data with demographic information, testing to see if sex, age, race, education and other factors could improve their predictions.
Catherine Roe, PhD, research assistant professor of neurology, described the findings as providing more evidence that scientists can detect Alzheimer's disease years before memory loss and cognitive decline become apparent.
The study, supported in part by the National Institute on Aging, appears in Neurology.
Source: ANI
Advertisement
The researchers found that all of the markers were equally good at identifying subjects who were likely to develop cognitive problems and at predicting how soon they would become noticeably impaired.
Next, the scientists paired the biomarkers data with demographic information, testing to see if sex, age, race, education and other factors could improve their predictions.
Catherine Roe, PhD, research assistant professor of neurology, described the findings as providing more evidence that scientists can detect Alzheimer's disease years before memory loss and cognitive decline become apparent.
The study, supported in part by the National Institute on Aging, appears in Neurology.
Source: ANI
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest General Health News
Most Americans confess that due to constant flurry of activity during the holiday season, it is difficult to eat nutritiously, exercise, and get enough sleep.
People who suffer from depression, constipation, and urinary tract infections are more likely to get multiple sclerosis(MS) five years before MS diagnosis.
Seeking internet help for an incomplete antibiotic course resulted in kidney stone formation and urinary tract infection in a young woman.
The Brain Care Score is a tool to evaluate brain health and reduce the risk of brain disorders including dementia and stroke.
Swine influenza A viruses, including subtypes H1N1, H1N2, and H3N2, are prominent among pigs and sporadically transmit to humans.